Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director
Por um escritor misterioso
Descrição
Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases
Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept
Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept
Frontiers Animal Production With Restrictive Use of Antibiotics to Contain Antimicrobial Resistance in Sweden—A Qualitative Study
Vetanco Vetanco registered products in Russia, Turkey and Azerbaijan - Vetanco
Sherry Layton - Chief Executive Officer - Vetanco USA
Vetanco Sherry Layton, closing keynote at the 3rd edition of the Animal Microbiome Congress Europe - Vetanco
Frontiers Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
New Trends in Vaccine Development
Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director
PDF) Biosurveillance of avian influenza and Newcastle disease viruses in the Barda region of Azerbaijan using real time RT-PCR and hemagglutination inhibition
Vaccines Conference-2022, Global Conference on Vaccines Research and Development
Frontiers Development of the Tonsil Microbiome in Pigs and Effects of Stress on the Microbiome
Vaccines Conference-2022, Global Conference on Vaccines Research and Development
de
por adulto (o preço varia de acordo com o tamanho do grupo)
format(webp))
